Chronic Obstructive Pulmonary Disease

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

What is Chronic Obstructive Pulmonary Disease?

Chronic obstructive pulmonary disease (COPD) is an assortment of lung disorders that includes...

Phenotyping of Chronic Obstructive Pulmonary Disease (COPD)

Types of Inhalers in Pulmonary Disease

Contemporary Topics in Pulmonary Medicine

What are the Differences between Asthma and COPD?

Chronic Obstructive Pulmonary Disease Process

Chronic Obstructive Pulmonary Disease Diagnosis

Chronic Obstructive Pulmonary Disease Causes

History of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Symptoms

COPD Risk Factors

Pulmonary Function Tests in COPD Progression Monitoring

See more featured articles »

Chronic Obstructive Pulmonary Disease Management

Foods That Can Irritate COPD

Latest Chronic Obstructive Pulmonary Disease News and Research

Metabolite patterns reveal potential for COPD population screening

The possibility of having a tool that facilitates population screening for Chronic Obstructive Pulmonary Disease (COPD) is getting closer.

5 Aug 2025

New Swiss study probes lingering fatigue after Legionnaires' disease

Researchers in Switzerland launched the LongLEGIO study to compare the long-term health impacts of Legionnaires’ disease and other bacterial pneumonias. Baseline data reveal key differences in comorbidities and quality of life between the groups, with follow-up underway.

4 Aug 2025

Which GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answers

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor agonist (GLP-1 RA) medications. Gastrointestinal symptoms were most common, while mental health concerns and tirzepatide-specific side effects were also flagged.

28 Jul 2025

APOE ε4 variant reveals hidden risk factors beyond Alzheimer’s

Researchers discovered that people carrying the APOE ε4 gene variant share a unique immune-related protein signature across their blood, brain, and cerebrospinal fluid—regardless of neurodegenerative disease diagnosis. This signature reveals a fundamental, disease-independent vulnerability linked to APOE ε4, reframing our understanding of genetic risk in conditions like Alzheimer's, Parkinson’s, ALS, and FTD.

21 Jul 2025

Exploring the genetic link between COPD and abdominal aortic aneurysm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Chronic obstructive pulmonary disease (COPD) and abdominal aortic aneurysm (AAA) are both severe conditions with complex etiologies and substantial comorbidities.

18 Jul 2025

New 3D bio-printed model closely mimics the complexity of natural lung tissue

UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an innovation that could transform how scientists study lung disease and develop new treatments.

15 Jul 2025

How a simple blood test can forecast future health risks

Plasma proteomics reveals that the biological ages of key organs, especially the brain and immune system, strongly predict the risk of future disease and early death. These organ-specific “clocks” provide a new tool for identifying those at highest risk and personalizing preventive care.

10 Jul 2025

Biological age of the brain emerges as a powerful predictor of longevity

The candles on your birthday cake don't tell the whole story. As anyone who ever attended a high-school reunion can tell you, some people age faster than others.

10 Jul 2025

Vaping linked to higher COPD risk, meta-analysis finds

A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds of developing COPD. The risk persists even after adjusting for smoking history, with former users at even greater risk than current users.

8 Jul 2025

Lung cells generated from mouse embryonic fibroblasts in just 7 to 10 days

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology.

3 Jul 2025

TET2 mutations in blood stem cells linked to lower Alzheimer's risk

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset Alzheimer's disease.

2 Jul 2025

Danish trial reveals how structured exercise and guidance affect life with chronic conditions

A large multicenter trial found that a 12-week personalized exercise therapy and self-management support program produced a small but statistically significant improvement in health-related quality of life for adults with multimorbidity. The intervention was safe, but its clinical relevance remains uncertain, as only self-rated health showed a significant benefit over usual care.

1 Jul 2025

How underreporting masks the real impact of RSV in older populations

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and diagnostic measures in healthcare.

1 Jul 2025

One in four patients with chronic respiratory diseases may face catastrophic health costs in Kenya

A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur 'catastrophic' health costs, new research published in The Lancet Global Health has found.

26 Jun 2025

Digital inhalers show promise in predicting COPD flare-ups

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study.

17 Jun 2025

Aging family physician workforce challenges primary care in Ontario

A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that many of those patients are elderly and have complex medical needs.

17 Jun 2025

Lung cells in COPD patients show higher levels of soot-like carbon deposits

Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of soot-like carbon deposits compared to cells taken from people who smoke but do not have COPD, according to a study published today (Wednesday) in ERJ Open Research.

10 Jun 2025

Long-term cardiorespiratory effects of wildfire smoke exposure revealed

Being exposed to lingering fine particulate matter (PM2.5) from wildfire smoke can have health effects up to three months afterwards, well beyond the couple of days that previous studies have identified, and the exposure can occur even after the fires have ended.

28 May 2025

Exploring how type 2 inflammation influences heart health and asthma

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Asthma and cardiovascular diseases (CVDs) are intricately linked, because of their widespread prevalence and shared pathophysiological processes.

28 May 2025

Lung function decline in COPD patients accelerated by mucus plug persistence

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants.

14 May 2025